-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NgN+GUvbf0UmmrsrI3qehNbSGHAHdACCJ9W+RLwbtcXZqii4GibrMUeOhTXZm9er rTqSZZfOcnhNKS/bAReafg== 0000217028-01-500004.txt : 20010427 0000217028-01-500004.hdr.sgml : 20010427 ACCESSION NUMBER: 0000217028-01-500004 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010426 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INTROGEN THERAPEUTICS INC CENTRAL INDEX KEY: 0001018710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 742704230 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-61001 FILM NUMBER: 1611771 BUSINESS ADDRESS: STREET 1: 301 CONGRESS AVE STREET 2: SUITE 1850 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 5127089310 MAIL ADDRESS: STREET 1: 301 CONGRESS AVE STREET 2: SUITE 1850 CITY: AUSTIN STATE: TX ZIP: 78701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RHONE POULENC RORER INC CENTRAL INDEX KEY: 0000217028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 231699163 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 500 ARCOLA RD STREET 2: P O BOX 1200 M/S 5B14 CITY: COLLEGEVILLE STATE: PA ZIP: 19426-0107 BUSINESS PHONE: 6104548000 FORMER COMPANY: FORMER CONFORMED NAME: RORER GROUP INC DATE OF NAME CHANGE: 19900731 FORMER COMPANY: FORMER CONFORMED NAME: RORER AMCHEM INC DATE OF NAME CHANGE: 19770604 SC 13G 1 introgen13g.txt INTROGEN 13G 2001 =========================================================================== SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Introgen Therapeutics, Inc. --------------------------------------- (Name of Issuer) COMMON STOCK, $.001 PAR VALUE --------------------------------------------------------------------------- (Title of Class of Securities) 46119F 10 7 ----------------- (CUSIP Number) October 19, 2000 ------------------------------------------------------- (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ x ] Rule 13d-1(d) =========================================================================== Page 1 of 5 There are no Exhibits 1 CUSIP No. 46119F 10 7 ___________________________________________________________________________ 1) Name of Reporting Person and its Rhone-Poulenc Rorer, Inc. I.R.S. Identification Number 23-1699163 ___________________________________________________________________________ 2) Check the Appropriate Box if (a)[ ] a Member of a Group (b)[ x ] ___________________________________________________________________________ 3) SEC Use Only ___________________________________________________________________________ 4) Citizenship or Place of Organization Delaware ___________________________________________________________________________ 5) Sole Voting Power 3,968,893 Number ___________________________________________________________ Shares Beneficially 6) Shared Voting Power 0 Owned by ____________________________________________________________ Each Reporting 7) Sole Dispositive Power 3,968,893 Person With ____________________________________________________________ 8) Shared Dispositive Power 0 ___________________________________________________________________________ 9) Aggregate Amount Beneficially Owned 3,968,893 by Each Reporting Person ___________________________________________________________________________ 10) Check Box If the Aggregate Amount [ ] in Row (9) Excludes Certain Shares ___________________________________________________________________________ 11) Percent of Class Represented 18.7% by Amount in Row (9) ___________________________________________________________________________ 12) Type of Reporting Person CO ___________________________________________________________________________ 2 CUSIP No. 46119F 10 7 This Statement on Schedule 13G (the "Schedule 13G") with respect to the Common Stock of Introgen Therapeutics, Inc. (the "Issuer"), is filed by Rhone-Poulenc Rorer, Inc., a Pennsylvania corporation ("RPR"), to reflect its deemed beneficial ownership of Common Stock of the Issuer, which was acquired before the Issuer had a class of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934. ITEM 1(a). NAME OF ISSUER: - --------- --------------- Introgen Therapeutics, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: - --------- ------------------------------------------------ 301 Congress Avenue Suite 1850 Austin, Texas 78701 ITEM 2(a). NAME OF PERSON FILING: - --------- ---------------------- Rhone-Poulenc Rorer, Inc. ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: - --------- ------------------------------------------------------------ Rhone-Poulenc Rorer, Inc. 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807 ITEM 2(c). CITIZENSHIP: - --------- ------------ Pennsylvania ITEM 2(d). TITLE OF CLASS OF SECURITIES: - --------- ----------------------------- Common Stock, $.001 Par Value ITEM 2(e): CUSIP NUMBER: - ---------- ------------- 46119F 10 7 3 CUSIP No. 46119F 10 7 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(b) OR - ------- 13D-2(b): ------------------------------------------------------------------- Not Applicable ITEM 4. OWNERSHIP: - ------- ---------- (a): AMOUNT BENEFICIALLY OWNED: As of 2/13/01 3,968,893 Shares Of Common Stock. (b): PERCENT OF CLASS: 18.7% (c): NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) Sole power to vote or to direct the vote: 3,968,893 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 3,968,893 (iv) Shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS - ------- -------------------------------------------- Not Applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER - ------- PERSON. -------------------------------------------------------- Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH - ------- ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY ---------------------------------------------------------- Rhone-Poulenc Rorer International (Holdings), Inc., a Delaware corporation and an indirectly wholly-owned subsidiary of RPR, is the record owner of the securities to which this statement relates. Its address is 3711 Kennett Pike, Suite 200, Greenville, Delaware 19801. 4 CUSIP No. 46119F 10 7 ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP - ------- --------------------------------------------------------- Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. - ------- ------------------------------- Not Applicable ITEM 10. CERTIFICATION. - -------- ----------------------- Not Applicable SIGNATURE ----------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. RHONE-POULENC RORER, INC. Date: February 13, 2001 By: /s/ Edward H. Stratemeier ----------------- ------------------------------ Edward H. Stratemeier Vice President -----END PRIVACY-ENHANCED MESSAGE-----